Maxcyte Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maxcyte company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maxcyte Company Profile Today - Breaking & Trending Today

Maher Masoud Purchases 70,443 Shares of MaxCyte, Inc. (NASDAQ:MXCT) Stock

MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) CEO Maher Masoud acquired 70,443 shares of the stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $4.90 per share, with a total value of $345,170.70. Following the completion of the purchase, the chief executive officer now owns 100,000 shares […] ....

United States , Maher Masoud , William Blair , Pricet Rowe Associates Inc , Maxcyte Company Profile , Maxcyte Inc , Roubaix Capital , Lazard Asset Management , Silvercrest Asset Management Group , Get Free Report , Asset Management Group , Asset Management , Maxcyte Daily ,

5,644,898 Shares in MaxCyte, Inc. (NASDAQ:MXCT) Acquired by Cadian Capital Management LP

Cadian Capital Management LP acquired a new position in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,644,898 shares of the company’s stock, valued at approximately $26,531,000. MaxCyte comprises about 1.1% of Cadian […] ....

United States , William Blair , Maxcyte Inc , Victory Capital Management Inc , Nisa Investment Advisors , China Universal Asset Management Co , Johnson Investment Counsel Inc , Maxcyte Company Profile , Securities Exchange Commission , Cadian Capital Management , Free Report , Capital Management , Investment Counsel , Investment Advisors , Universal Asset Management , Aigen Investment Management , Get Free Report , Visit Holdingschannel , Maxcyte Daily ,

MaxCyte (NASDAQ:MXCT) Sees Large Volume Increase

MaxCyte (NASDAQ:MXCT) Sees Large Volume Increase
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , William Blair , Us Bancorp , Russell Investments Group Ltd , River Global Investors , Mirae Asset Global Investments Co , Maxcyte Inc , Maxcyte Company Profile , Chevy Chase Trust Holdings , Get Free Report , Investments Group , Global Investors , Chase Trust Holdings , Mirae Asset Global Investments , Maxcyte Daily ,

Valmark Advisers Inc. Buys New Shares in MaxCyte, Inc. (NASDAQ:MXCT)

Valmark Advisers Inc. bought a new stake in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 83,927 shares of the company’s stock, valued at approximately $394,000. Valmark Advisers Inc. owned about 0.08% of MaxCyte […] ....

United States , William Blair , Alberta Investment Management Corp , Maxcyte Company Profile , Maven Securities , Sg Americas Securities , Blair William Co , Exchange Commission , Valmark Advisers Inc , Maxcyte Inc , Valmark Advisers , Free Report , Investment Counsel , Investment Management Corp , Get Free Report , Maxcyte Daily , Nasdaq Mxct , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

MaxCyte's (MXCT) "Overweight" Rating Reiterated at Stephens

MaxCyte's (MXCT) "Overweight" Rating Reiterated at Stephens
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , William Blair , Nisa Investment Advisors , Financial Services Group Inc , Maxcyte Company Profile , Maxcyte Inc , Johnson Investment Counsel Inc , Victory Capital Management Inc , Free Report , Cyte Trading Down , Get Free Report , Services Group , Capital Management , Investment Counsel , Investment Management , Investment Advisors , Maxcyte Daily ,